LOADING
Comparing Eli Lilly and Company (LLY) and Broadcom Inc (AVGO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | LLY | AVGO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.03T | $1.85T |
| P/E Ratio | 40.8 | 65.0 |
| Forward P/E | 33.9 | 20.8 |
| PEG Ratio | 1.61 | 0.44 |
| EPS | $28.15 | $5.99 |
| Revenue Growth (YoY) | 55.5% | 47.9% |
| Profit Margin | 35.0% | 38.9% |
| Return on Equity | 107.5% | 37.3% |
| Dividend Yield | 0.54% | 0.65% |
| Beta | 0.51 | 1.46 |
| 52-Week High | $1,249.45 | $494.18 |
| 52-Week Low | $619.40 | $279.80 |
| Volume | -- | -- |
Broadcom Inc is the larger company by market capitalization. Eli Lilly and Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Broadcom Inc offers a higher dividend yield for income investors. Broadcom Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.